Announcements Regarding Impact of COVID-19 Response on HIRO Operations (Updated 9/18/2020):   Read more

Acknowledging the HIRO in Your Research

If you utilize the services of the HIRO for your research study or clinical trial, we would greatly appreciate acknowledgment in any resulting academic presentations or publications. Similarly, if you are writing a grant proposal and need to provide a description of the University's available facilities and resources, including the HIRO will strengthen your application. To properly acknowledge and/or describe the HIRO, please utilize the boilerplate language below. For questions regarding acknowledgment, please contact us at hirohelp [at] bsd [dot] uchicago [dot] edu.

In the "Acknowledgments" section of a publication/presentation

The authors would like to thank The University of Chicago's Human Imaging Research Office (HIRO) for their assistance in coordinating the imaging aspects of this study and providing anonymized, compliant images for evaluation. The HIRO is supported in part by pilot research funding provided by the Virginia and D. K. Ludwig Fund for Cancer Research via the Imaging Research Institute in the Biological Sciences Division of the University of Chicago and through Cancer Center Support Grant number P30 CA014599 from the University of Chicago Comprehensive Cancer Center.

Within the text of a publication

Acknowledgement and citation

Subjects were scanned according to trial protocol with the assistance of The University of Chicago's Human Imaging Research Office (HIRO)1,2, which also provided anonymized, compliant images for evaluation.

  1. Armato SG, Gruszauskas NP, MacMahon H, Torno MD, Li F, Engelmann RM, Starkey A, Pudela CL, Marino JS, Santiago F, Chang PJ, Giger ML. Research imaging in an academic medical center. Acad Radiol 2012; 19(6): 762-771.
  2. Gruszauskas NP, Armato SG. Critical Challenges to the Management of Clinical Trial Imaging: Recommendations for the Conduct of Imaging at Investigational Sites. Acad Radiol 2020; 27(2): 300-306.

Cancer Center Members should also include the following acknowledgement

This project was supported, in part, by the University of Chicago Medicine Comprehensive Cancer Center Support Grant (#P30 CA14599) and the services provided by the Human Imaging Research Office.

Within the "Facilities & Resources" section of a grant application

The Human Imaging Research Office (HIRO) in The University of Chicago's Biological Sciences Division provides a dedicated infrastructure to assist with issues related to the acquisition, collection, and distribution of clinical imaging examinations and associated data for use in research. The HIRO was created with three primary responsibilities: (1) coordinate the acquisition of images for clinical research per the study protocol's imaging guidelines and parameters, (2) provide reliable and consistent assessment of disease response for clinical research, and (3) manage and distribute medical imaging exams for research purposes in a compliant manner. The HIRO currently provides assistance for over 350 clinical research studies from 15 sections and departments within our medical center. The HIRO has fulfilled over 9700 requests for medical imaging data, delivering over 110000 imaging examinations and related reports to investigators for research purposes. The HIRO has supported clinical trials at our institution that are sponsored by numerous different companies, including: AbbVie, AstraZeneca, Astrellas, Bayer, Biogen, Boston Scientific, Bristol-Myers Squibb, Hoffman-La Roche, Genentech, Genzyme, Gilead, GlaxoSmithKline, InCyte, Janssen, MedImmune, Medtronic, Merck, Novartis, Pfizer, Pharmacyclics, and Sanofi Aventis. The HIRO has also supported clinical trials at our institution that are sponsored by cooperative groups like ACOSOG, ACRIN, Alliance, CALGB, COG, ECOG, GOG, NCI, and RTOG. Implementation of the HIRO has increased the level of satisfaction and interaction among investigators, research subjects, radiologists, and other imaging professionals.